INSIGHTS ON DRUG DEVELOPMENT
-
The Top Tech Transfer Risks At Multi-Site CDMOs
Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
-
Sustainable Manufacturing Through Automation, Flow Chemistry, And Biocataysis
Learn how modeling, high-throughput tools, and advanced analytics enable safer, more efficient routes and support scalable solutions for complex chemical and enzymatic processes.
-
Spray Dried Biologics For Injectable Dosage Forms
Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
New And Upcoming Trends In Immunodiagnostics
Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era4/21/2026
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
Why Biopharma Breakthroughs Aren't Moving The Market10/20/2025
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs10/3/2024
Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease8/2/2024
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
DRUG DEVELOPMENT SOLUTIONS
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Examine how sterilizing-grade filters with high flux and broad compatibility support efficient bioprocessing across mAbs, vaccines, and viral vectors.